Company · Mississauga, Ontario, Canada

Baxter Corporation

Everything this company holds in Health Canada’s product databases, as the company’s name is spelled there.

Drug products (DIN): 363; 140 authorized now
Natural health products: 0; 0 active licences
Medical device licences: 21; 0 active
Notices of Compliance: 198

Drug products

Authorized products first.

Name	DIN	Status	Status since
(20 MMOL/L) POTASSIUM CHLORIDE IN 3.3% DEXTROSE AND 0.3% SODIUM CHLORIDE INJECTION USP	00438014	Marketed	Jan 2013
(20 MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.9% SODIUM CHLORIDE INJECTION USP	00786292	Marketed	Jan 2013
(20 MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE INJECTION USP	00438049	Marketed	Jan 2013
(20MMOL/L) POTASSIUM CHLORIDE IN 0.9% SODIUM CHLORIDE INJECTION USP	00786209	Marketed	Jan 2013
(20MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP	00437999	Marketed	Jan 2013
(40 MMOL/L) POTASSIUM CHLORIDE IN 0.9% SODIUM CHLORIDE INJECTION USP	00786217	Marketed	Jan 2013
(40 MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE INJECTION USP	00438030	Marketed	Jan 2013
(40MMOL/L) POTASSIUM CHLORIDE IN 3.3% DEXTROSE AND 0.3% SODIUM CHLORIDE INJECTION USP	00438022	Marketed	Jan 2013
(40MMOL/L)POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP	00438006	Marketed	Jan 2013
0.4% LIDOCAINE HYDROCHLORIDE AND 5% DEXTROSE INJECTION	00828602	Marketed	Dec 2019
0.9% SODIUM CHLORIDE INJECTION, USP	00060208	Marketed	Feb 2019
0.9% SODIUM CHLORIDE IRRIGATION, USP	00786160	Marketed	Jan 2021
10% DEXTROSE INJECTION, USP	00060364	Marketed	Mar 2019
12% SODIUM CHLORDIE PROCESSING SOLUTION	00783625	Marketed	Dec 1991
20% PROSOL	02141450	Marketed	Jan 2015
20% SODIUM CHLORIDE INJECTION, BP	02514184	Marketed	Jul 2022
5% DEXTROSE INJECTION, USP	00060348	Marketed	Mar 2019
70% DEXTROSE INJECTION USP	02014874	Marketed	Jan 2015
ACETAMINOPHEN INJECTION	02519305	Marketed	Jan 2023
AERRANE	02225875	Marketed	Oct 2002
ANTICOAGULANT SOD CITRATE SOLTN 4GM/100ML	00060313	Marketed	Dec 1990
ANTICOAGULANT SODIUM CITRATE 4% W/V SOLUTION, USP	02377411	Marketed	Jun 2024
ARTISS	02326167	Marketed	Dec 2016
AXBERI	02539977	Marketed	Oct 2024
AXBERI	02539985	Marketed	Oct 2024
AXBERI	02540002	Marketed	Oct 2024
AXBERI	02540010	Marketed	Oct 2024
AXBERI	02540045	Marketed	Oct 2024
AXBERI HP	02540029	Marketed	Oct 2024
AXBERI HP	02540037	Marketed	Oct 2024
BREVIBLOC INJECTION 10MG/ML	02188880	Marketed	Aug 2000
BREVIBLOC PREMIXED INJECTION	02309238	Marketed	Sep 2008
BUPIVACAINE HYDROCHLORIDE INJECTION, USP	02488930	Marketed	Aug 2022
CAELYX	02238389	Marketed	Mar 2022
CALCIUM GLUCONATE INJECTION, USP 10%	02523140	Marketed	Jun 2022
CEFAZOLIN IN DEXTROSE INJECTION, USP	02496313	Marketed	Mar 2025
CEFTRIAXONE INJECTION, USP	02499711	Marketed	Mar 2021
CEFTRIAXONE INJECTION, USP	02499738	Marketed	Mar 2021
CLINDAMYCIN INJECTION IN 5% DEXTROSE	02485478	Marketed	Nov 2019
CLINDAMYCIN INJECTION IN 5% DEXTROSE	02485486	Marketed	Dec 2019
CLINIMIX	02013886	Marketed	Nov 2013
CLINIMIX	02013940	Marketed	Nov 2013
CLINIMIX	02046709	Marketed	Nov 2013
CLINIMIX	02013932	Marketed	Nov 2013
CLINIMIX	02498448	Marketed	Apr 2022
CLINIMIX	02498456	Marketed	Apr 2023
CLINIMIX	02498464	Marketed	Nov 2020
CLINIMIX E	02014076	Marketed	Nov 2013
CLINIMIX E	02013967	Marketed	Nov 2013
CLINIMIX E	02142384	Marketed	Nov 2013
CLINIMIX E	02498413	Marketed	Oct 2021
CLINIMIX E	02498421	Marketed	Dec 2020
CLINOLEIC 20%	02344327	Marketed	Mar 2012
CYSTOSOL W 3% HEXITOLS	00799963	Marketed	Dec 1989
DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION, USP	02513978	Marketed	Jun 2024
DEXTROSE 0.2% AND 0.9% SOD CHLOR SOLUTION	00783641	Marketed	Dec 1991
DEXTROSE 10% AND 0.9% SOD CHLORIDE INJ	00060755	Marketed	Dec 1990
DEXTROSE 3.3% AND 0.3% SOD CHLORIDE INJ	00060712	Marketed	Dec 1990
DEXTROSE 5% AND 0.2% SOD CHLORIDE INJ	00060704	Marketed	Dec 1990
DEXTROSE 5% AND 0.45% SOD CHLORIDE INJ	00060739	Marketed	Dec 1990
DEXTROSE 5% AND 0.9% SOD CHLORIDE INJ	00060747	Marketed	Dec 1990
DOPAMINE HCL 0.8MG/ML DEXTROSE 5% INJ USP	00761850	Marketed	Dec 1992
DOPAMINE HCL 1.6MG/ML DEXTROSE 5% INJ USP	00761826	Marketed	Dec 1990
DOPAMINE HCL 3.2MG/ML DEXTROSE 5% INJ USP	00761834	Marketed	Dec 1990
FLUCONAZOLE IN SODIUM CHLORIDE INJECTION USP	02261472	Marketed	Feb 2017
FORANE	02188856	Marketed	Jan 2000
GENTAMICIN(E)	02082136	Marketed	Dec 1995
GENTAMICIN(E)	02082152	Marketed	Dec 1995
GLYCINE 1.5% IRRIGATION USP SOL	00799955	Marketed	Dec 1989
HEPARIN SOD AND 0.9% SOD CHLORIDE INJ	00828750	Marketed	Dec 1990
IFEX	02241356	Marketed	Sep 2003
IFEX	02241357	Marketed	Sep 2003
LACTATED RINGER'S AND 5% DEXTROSE INJECTION, USP	00061131	Marketed	Dec 1973
LACTATED RINGER'S INJ	00881600	Marketed	Dec 1991
LACTATED RINGER'S INJECTION, USP	00061085	Marketed	Dec 1957
LACTATED RINGER'S IRRIGATION SOL	00799971	Marketed	Dec 1989
MAGNESIUM SULFATE IN WATER FOR INJECTION	02542153	Marketed	Nov 2024
MAGNESIUM SULFATE INJECTION, BP 49.3%	02513161	Marketed	Oct 2021
METOCLOPRAMIDE HYDROCHLORIDE INJECTION	02531747	Marketed	Jun 2024
METRONIDAZOLE INJECTION, USP	00870420	Marketed	Sep 2019
MYXREDLIN	02529602	Marketed	Jul 2023
NITROGLYCERIN IN 5% DEXTROSE INJ.-200MCG/ML	02145308	Marketed	Dec 1995
NITROGLYCERIN IN 5% DEXTROSE INJ.-400MCG/ML	02145316	Marketed	Dec 1995
NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE INJECTION	02501430	Marketed	Jul 2021
NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE INJECTION	02501449	Marketed	Jul 2021
OLIMEL 5.7%	02352540	Marketed	Sep 2019
OLIMEL 5.7% E	02352532	Marketed	Jan 2011
OLIMEL 7.6%	02477947	Marketed	Jul 2021
OLIMEL 7.6% E	02477955	Marketed	Oct 2018
OSMITROL INJECTION 10%	00060410	Marketed	May 2020
OSMITROL INJECTION 20%	00060437	Marketed	May 2020
PERIOLIMEL 2.5% E	02352494	Marketed	Feb 2011
PLASMA-LYTE A INJECTION	02339358	Marketed	Dec 2010
POTASS CHLOR 40MEQ 5% DEX AND 0.9% SOD CHLOR	00786306	Marketed	Dec 1990
POTASSIUM CHLORIDE IN LACTATED RINGER'S INJECTION	02243421	Marketed	May 2001
POTASSIUM CHLORIDE IN SODIUM CHLORIDE INJECTION USP	02269414	Marketed	Mar 2008
POTASSIUM CHLORIDE INJECTION	02241676	Marketed	Aug 2000
POTASSIUM CHLORIDE INJECTION	02241677	Marketed	Aug 2000
POTASSIUM CHLORIDE INJECTION	02241679	Marketed	Aug 2000
PRIMENE 10%	02236875	Marketed	Dec 2014
PROCYTOX	02241795	Marketed	Oct 2003
PROCYTOX	02241796	Marketed	Sep 2003
PROCYTOX	02241797	Marketed	Aug 2003
PROCYTOX	02241798	Marketed	Jul 2003
PROCYTOX	02241799	Marketed	Nov 2003
PROCYTOX	02241800	Marketed	Nov 2003
PROPOFOL INJECTION	02244379	Marketed	Sep 2022
SEVOFLURANE	02265974	Marketed	Apr 2007
SODIUM CHLORIDE 0.45% INJ	00060186	Marketed	Dec 1990
SODIUM CHLORIDE 3% INJ	00060232	Marketed	Dec 1990
STERILE WATER FOR INJECTION, USP	02014882	Marketed	Jan 2015
STERILE WATER FOR IRRIGATION, USP	00799998	Marketed	Dec 2020
SUPRANE	02227428	Marketed	Aug 2000
TIS-U-SOL SOLUTION	00800007	Marketed	Dec 1990
TISSEEL	02326132	Marketed	Feb 2016
TISSEEL	02326175	Marketed	Apr 2016
TRAVASOL	00872296	Marketed	Oct 2013
UROMITEXAN	02241411	Marketed	Jan 2004
UROMITEXAN	02371839	Marketed	Apr 2012
VANCOMYCIN INJECTION USP IN 0.9% SODIUM CHLORIDE	02487071	Marketed	Jan 2021
BUPIVACAINE HYDROCHLORIDE INJECTION, USP	02488914	Approved	May 2019
BUPIVACAINE HYDROCHLORIDE INJECTION, USP	02488922	Approved	May 2019
EPHEDRINE SULFATE INJECTION, USP	02544148	Approved	Dec 2023
ERIBULIN MESYLATE INJECTION	02560399	Approved	Oct 2025
FUROSEMIDE INJECTION, USP	02488868	Approved	May 2019
KETAMINE INJECTION, BP	02525836	Approved	Mar 2022
MAGNESIUM SULFATE IN WATER FOR INJECTION	02542161	Approved	Oct 2023
MICAFUNGIN IN 0.9% SODIUM CHLORIDE INJECTION	02560488	Approved	Sep 2025
MICAFUNGIN IN 0.9% SODIUM CHLORIDE INJECTION	02560496	Approved	Sep 2025
MICAFUNGIN IN 0.9% SODIUM CHLORIDE INJECTION	02560518	Approved	Sep 2025
MIDAZOLAM INJECTION, USP	02529300	Approved	Jul 2022
MIDAZOLAM INJECTION, USP	02529319	Approved	Jul 2022
NALOXONE HYDROCHLORIDE INJECTION, USP	02518066	Approved	Jul 2021
NALOXONE HYDROCHLORIDE INJECTION, USP	02518074	Approved	Jul 2021
ONDANSETRON INJECTION, USP	02499177	Approved	May 2020
ONDANSETRON INJECTION, USP	02499185	Approved	May 2020
ONDANSETRON INJECTION, USP	02527286	Approved	May 2022
TRANEXAMIC ACID INJECTION, USP	02505274	Approved	Sep 2020
TRANEXAMIC ACID INJECTION, USP	02505282	Approved	Sep 2020
VANCOMYCIN INJECTION USP IN 5% DEXTROSE	02487063	Approved	Apr 2019
(20MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.2% SODIUM CHLORIDE INJECTION USP	00503142	Cancelled Post Market	Jul 2016
(40 MMOLS/L) POTASSIUM CHLORIDE IN LACTATED RINGER'S INJECTION USP	02246134	Cancelled Post Market	Jul 2016
1.6% SODIUM CHLORDIE PROCESSING SOLUTION	00783633	Cancelled Post Market	Dec 2022
16.4% SODIUM ACETATE INJECTION, USP	02247204	Cancelled Post Market	May 2011
20% DEXTROSE INJECTION, USP	02015080	Cancelled Post Market	Jul 2025
23.4% SODIUM CHLORIDE INJECTION USP	02245934	Cancelled Post Market	May 2011
33.3% DEXTROSE INJECTION, USP	02014831	Cancelled Post Market	Jul 2025
40% DEXTROSE INJECTION, USP	02014858	Cancelled Post Market	Jul 2025
50% DEXTROSE INJECTION, USP	02014866	Cancelled Post Market	Jul 2025
800 SODIUM BICARBONATE POWDER	00774995	Cancelled Post Market	Jul 2021
ACID CONCENTRATE 2100	00774243	Cancelled Post Market	Aug 2004
ACID CONCENTRATE 2101	00774790	Cancelled Post Market	Aug 2004
ACID CONCENTRATE 2102	00774804	Cancelled Post Market	Jul 2025
ACID CONCENTRATE 2105	00774839	Cancelled Post Market	Aug 2004
ACID CONCENTRATE 2106	02239609	Cancelled Post Market	Aug 2007
ACID CONCENTRATE 2113	02210037	Cancelled Post Market	Aug 2002
ACID CONCENTRATE 2116	00774936	Cancelled Post Market	Aug 2020
ACID CONCENTRATE 2117	00774944	Cancelled Post Market	Aug 2020
ACID CONCENTRATE 2119	02239483	Cancelled Post Market	Aug 2007
ACID CONCENTRATE 2120	00774960	Cancelled Post Market	Dec 2018
ACID CONCENTRATE 2121	00774979	Cancelled Post Market	Aug 2007
ACID CONCENTRATE 2122	02237690	Cancelled Post Market	Aug 2004
ACID CONCENTRATE 2123	02242549	Cancelled Post Market	Aug 2004
ACID CONCENTRATE 2125	00770213	Cancelled Post Market	Dec 2018
ACID CONCENTRATE 2126	02242547	Cancelled Post Market	Aug 2020
ACID CONCENTRATE 2128	02239482	Cancelled Post Market	Aug 2007
ACID CONCENTRATE 2129	02239481	Cancelled Post Market	Aug 2004
ACID CONCENTRATE 2131	02239480	Cancelled Post Market	Aug 2007
ACID CONCENTRATE 2132	02210045	Cancelled Post Market	Aug 2004
ACID CONCENTRATE 2135	00771244	Cancelled Post Market	Nov 2024
ACID CONCENTRATE 2139	00771279	Cancelled Post Market	Dec 2018
ACID CONCENTRATE 2147	02239479	Cancelled Post Market	Aug 2007
ACID CONCENTRATE 2148	02239478	Cancelled Post Market	Aug 2004
ACID CONCENTRATE 2151	02239486	Cancelled Post Market	Aug 2020
ACID CONCENTRATE 2152	02210061	Cancelled Post Market	Dec 2018
ACID CONCENTRATE 2155	02239489	Cancelled Post Market	Aug 2004
ACID CONCENTRATE 2161	02210096	Cancelled Post Market	Jul 2025
ACID CONCENTRATE 2162	02209942	Cancelled Post Market	Aug 2004
ACID CONCENTRATE 2163	02209780	Cancelled Post Market	Jul 2025
ACID CONCENTRATE 2171	02210134	Cancelled Post Market	Dec 2018
ACID CONCENTRATE 2175	02210150	Cancelled Post Market	Aug 2002
ACID CONCENTRATE 2185	02239485	Cancelled Post Market	Aug 2007
ACID CONCENTRATE 2186	02209950	Cancelled Post Market	Jul 2005
ACID CONCENTRATE 2189	02210010	Cancelled Post Market	Aug 2007
ACID CONCENTRATE 2190	02239484	Cancelled Post Market	Aug 2007
ACID CONCENTRATE 2195	02209985	Cancelled Post Market	Jul 2005
ACID CONCENTRATE 2198	02239490	Cancelled Post Market	Dec 2018
ACID CONCENTRATE 3186	00883530	Cancelled Post Market	Aug 2002
ACID CONCENTRATE 3187	00883549	Cancelled Post Market	Aug 2002
ACID CONCENTRATE D-12287	02239487	Cancelled Post Market	Aug 2004
ACID CONCENTRATE D-18003	02158132	Cancelled Post Market	Aug 2002
ACID CONCENTRATE D-18006	02158361	Cancelled Post Market	Aug 2002
ACID CONCENTRATE D12093	00665665	Cancelled Post Market	Aug 2002
ACID CONCENTRATE D12094	00665673	Cancelled Post Market	Aug 2004
ACID CONCENTRATE D12095	00665681	Cancelled Post Market	Aug 2002
ACID CONCENTRATE D12112	00742171	Cancelled Post Market	Aug 2002
ACID CONCENTRATE D12117	00770280	Cancelled Post Market	Aug 2007
ACID CONCENTRATE D12135	00850446	Cancelled Post Market	Aug 2002
ACID CONCENTRATE D12143	00798304	Cancelled Post Market	Aug 2004
ACID CONCENTRATE D12146	00804673	Cancelled Post Market	Aug 2007
ACID CONCENTRATE D12167	00860522	Cancelled Post Market	Aug 2007
ACID CONCENTRATE D12185	00860417	Cancelled Post Market	Aug 2004
ACID CONCENTRATE D12186	00860425	Cancelled Post Market	Dec 2018
ACID CONCENTRATE D12188	00860611	Cancelled Post Market	Nov 2024
ACID CONCENTRATE D12203	00860468	Cancelled Post Market	Aug 2020
ACID CONCENTRATE D12204	00860549	Cancelled Post Market	Aug 2002
ACID CONCENTRATE D12209	00890200	Cancelled Post Market	Aug 2004
ACID CONCENTRATE D12221	02158345	Cancelled Post Market	Aug 2002
ACID CONCENTRATE D12255	02158256	Cancelled Post Market	Nov 2024
ACID CONCENTRATE D12259	02158191	Cancelled Post Market	Aug 2002
ACID CONCENTRATE D12265	02158167	Cancelled Post Market	Aug 2020
ACID CONCENTRATE D12267	02158108	Cancelled Post Market	Aug 2002
ACID CONCENTRATE D12270	02178109	Cancelled Post Market	Aug 2004
ACID CONCENTRATE D12271	02178117	Cancelled Post Market	Aug 2002
ACID CONCENTRATE D12273	02178133	Cancelled Post Market	Aug 2017
ACID CONCENTRATE D12274	02178141	Cancelled Post Market	Aug 2004
ACID CONCENTRATE D12282	02218852	Cancelled Post Market	Aug 2007
ACID CONCENTRATE D12284	02220334	Cancelled Post Market	Aug 2002
ACID CONCENTRATE D12285	02220326	Cancelled Post Market	Aug 2002
ACID CONCENTRATE D12292	02217236	Cancelled Post Market	Dec 2018
ACID CONCENTRATE D12301	02217651	Cancelled Post Market	Aug 2004
ACID CONCENTRATE D12304	02218860	Cancelled Post Market	Jul 2025
ACID CONCENTRATE D12306	02160870	Cancelled Post Market	Jul 2025
ACID CONCENTRATE D12308	02244097	Cancelled Pre Market	Jun 2025
ACID CONCENTRATE D12308	02250810	Cancelled Pre Market	Jun 2025
ACID CONCENTRATE D12309	02244098	Cancelled Pre Market	Jun 2025
ACID CONCENTRATE D12309	02250829	Cancelled Pre Market	Jun 2025
ACID CONCENTRATE D12310	02244099	Cancelled Pre Market	Jun 2025
ACID CONCENTRATE D12311	02244100	Cancelled Pre Market	Jun 2025
ACID CONCENTRATE D12311	02250837	Cancelled Pre Market	Jun 2025
ALBUMIN (HUMAN) 25% SOLUTION	00427659	Cancelled Post Market	Mar 2008
ALBUMIN (HUMAN) 5% SOLUTION	00427675	Cancelled Post Market	Mar 2008
ALCOHOL 5% AND DEXTROSE 5% INJ USP	00060879	Cancelled Post Market	Jul 2025
ANTICOAGULANT CIT PHOS DEX ADENINE SOL USP	01960865	Cancelled Post Market	Jul 2025
ANTITHROMBIN III IMMUNO	02237812	Cancelled Post Market	Oct 2011
BASIC FOLEY CATH KIT IODOPHOR PVP PAD 1%	01945777	Cancelled Post Market	Aug 1999
BCAA 4% INJ	00890901	Cancelled Post Market	May 2011
BICARBONATE CHLORIDE D12052	00732494	Cancelled Post Market	Aug 2002
BICARBONATE CONCENTRATE 4105	00771295	Cancelled Post Market	Aug 2002
BICARBONATE CONCENTRATE D16000	00691658	Cancelled Post Market	Aug 2007
BICARBONATE CONCENTRATE D16001	00691631	Cancelled Post Market	Aug 2007
BICARBONATE CONCENTRATE D20000	00821616	Cancelled Post Market	Aug 2002
BICART	00882666	Cancelled Post Market	Jul 2025
BREVIBLOC INJECTION 250MG/ML	02188864	Cancelled Post Market	Jun 2007
CALCIUM-35 0.25 - 4.5	00798711	Cancelled Post Market	Aug 2002
CALCIUM-36.8 0.25-4.5	02161001	Cancelled Post Market	Aug 2004
CIPROFLOXACIN INJECTION	02301296	Cancelled Post Market	Jul 2020
CIPROFLOXACIN INJECTION, USP	02289946	Cancelled Post Market	Jun 2010
CLINDAMYCIN INJECTION IN 5% DEXTROSE	02485451	Cancelled Post Market	Mar 2023
CLINIMIX	02013959	Cancelled Post Market	Jun 2018
CLINIMIX	02013916	Cancelled Post Market	Jul 2016
CLINIMIX	02013924	Cancelled Post Market	Jul 2016
CLINIMIX	02142260	Cancelled Post Market	Dec 2022
CLINIMIX	02142279	Cancelled Post Market	Apr 2022
CLINIMIX E	02014025	Cancelled Post Market	Jun 2018
CLINIMIX E	02014084	Cancelled Post Market	Jul 2016
CLINIMIX E	02014041	Cancelled Post Market	Jun 2018
CLINIMIX E	02014068	Cancelled Post Market	Mar 2021
CLINIMIX E	02142341	Cancelled Post Market	Jun 2018
CLINIMIX E	02142376	Cancelled Post Market	Jun 2022
CONTINUOUS EPIDURAL ANESTHESIA TRAY	01909517	Cancelled Post Market	Jul 2001
DAPTOMYCIN FOR INJECTION RF	02518856	Cancelled Pre Market	Dec 2025
DEXTROSE 2.5% AND SOD CHLORIDE 0.45% INJ USP	00060720	Cancelled Post Market	Dec 2012
DEXTROSE 5% AND ELECTROLYTE NO75 INJ	00261335	Cancelled Post Market	May 2011
DEXTROSE 5% AND SOD CHLORIDE 0.33% INJ USP	00786179	Cancelled Post Market	Jul 2025
DEXTROSE-35 5.55 - 4.5	00798908	Cancelled Post Market	Aug 2002
DEXTROSE-36.8 5.55-4.5	02161044	Cancelled Post Market	Aug 2004
DEXTROSE-45 5.55-4.5	02160978	Cancelled Post Market	Jul 2020
DIANEAL PD 102 CAPD SOLUTION W 1.5% DEXTROSE	00799831	Cancelled Post Market	Aug 2002
DIANEAL PD 102 CAPD SOLUTION W 4.25% DEXTROSE	00799858	Cancelled Post Market	Aug 2002
DIANEAL PD 104 CAPD SOLUTION W 0.5% DEXTROSE	00799890	Cancelled Post Market	Jul 2000
DIANEAL PD109 CAPD SOLUTION	00799947	Cancelled Post Market	Aug 2004
ENLON 10MG/ML	02188848	Cancelled Post Market	Jan 2008
EPIDURAL ANESTHESIA TRAY	02003856	Cancelled Post Market	Jul 2001
EPIDURAL ANESTHESIA TRAY	02003864	Cancelled Post Market	Jul 2000
ETHRANE LIQUID INH	02188899	Cancelled Post Market	Aug 2004
EXCHANGE TRANSFUSION TRAY 10%	01949144	Cancelled Post Market	Aug 1999
FOLEY CATHETERIZATION TRAY 10%KIT	01944509	Cancelled Post Market	Aug 1999
FSME-IMMUN	02264625	Cancelled Post Market	Mar 2014
GAMMAGARD S/D (IV)	02231468	Cancelled Post Market	Nov 2013
GENTAMICIN(E) 120MG LIQ IV 1.2MG/ML	02082144	Cancelled Post Market	Jul 2016
GENTRAN 40 10% DEXTROSE 5% INJ	00454915	Cancelled Post Market	May 2008
GENTRAN 40 10% SODIUM CHLORIDE 0.9% INJ	00454923	Cancelled Post Market	May 2008
GENTRAN-70 6% & SODIUM CHLORIDE 0.9% INJ	01981722	Cancelled Post Market	May 2008
HEPARIN SODIUM & 5% DEXTROSE INJECTION LIQ	02008181	Cancelled Post Market	Feb 2011
HEPARIN SODIUM & DEXTROSE 5% IN VIAFLEX LIQ	01900757	Cancelled Post Market	Feb 2011
HEPARIN SODIUM AND DEXTROSE 5% INJ USP	01913255	Cancelled Post Market	Feb 2011
IRRIGATION TRAY 10% KIT	01944533	Cancelled Post Market	Aug 1999
IRRIGATION TRAY W BENZALKONIUM PAD 1:750	01945785	Cancelled Post Market	Aug 1999
IRRIGATION TRAY W PVP-I PREP PAD 1%	01945769	Cancelled Post Market	Aug 1999
IVEEGAM IMMUNO 5000MG (IV)	01959301	Cancelled Post Market	Dec 2008
K+36.8	00798258	Cancelled Post Market	Aug 2002
LACTATE CHLORIDE DEXTROSE INJ	00060976	Cancelled Post Market	Dec 2012
LIDOCAINE HCL 0.2% AND DEXTROSE 5% INJ	00828599	Cancelled Post Market	Feb 2016
LIDOCAINE HCL 0.8% AND 5% DEXTROSE INJ	00828610	Cancelled Post Market	Feb 2016
MAGNESIUM-35 0.5 - 4.5	00890170	Cancelled Post Market	Aug 2002
MAGNESIUM-36.8 0.5-4.5	02161036	Cancelled Post Market	Aug 2002
MULTIPLE ELECTROLYTE ADDITIVE LIQ FORMULA 1	00809551	Cancelled Post Market	Oct 2015
NITROGLYCERIN IN 5% DEXTROSE INJ.-100MCG/ML	02145294	Cancelled Post Market	Feb 2016
NUTRINEAL PD4	02230810	Cancelled Post Market	Nov 2021

Showing 300 of 363 drug products. For the rest, search Health Canada’s database.

Medical device licences

Active licences first, newest first.

Name	Licence	Status	First licensed
IV TRANSFER SET WITH VIAFLEX CONTAINER	83750	Cancelled · Class 2	Aug 2010
IV EXTENSION SET	80309	Cancelled · Class 2	Jul 2009
EASYSPRAY PRESSURE REGULATOR	70045	Discontinued at renewal · Class 2	Dec 2005
EVA PARENTERAL NUTRITION CONTAINER	60206	Discontinued at renewal · Class 2	Aug 2002
VIAFLEX CONTAINER	38520	Cancelled · Class 2	May 2002
RECIRCULATION LUER LOCK ADAPTOR	34206	Discontinued at renewal · Class 2	Nov 2001
BUFFY COAT POOLING SET	33670	Discontinued at renewal · Class 2	Nov 2001
TISSOMAT SPRAY DEVICE	33622	Discontinued at renewal · Class 2	Nov 2001
INTRA-VENOUS TUBING SET	32793	Discontinued at renewal · Class 2	Oct 2001
OPTI PRESS II	30010	Discontinued at renewal · Class 2	Jun 2001
TRANS URETHRAL RESECTION(TUR) IRRIGATION SETS	35889	Cancelled · Class 2	Nov 1999
IV SOLUTION SET	14659	Cancelled · Class 2	Nov 1999
BURETROL IV SOLUTION SETS	35890	Cancelled · Class 2	Nov 1999
INTERLINK SYSTEM CONTINU-FLO SOLUTION SET	9890	Discontinued at renewal · Class 2	Aug 1999
DUPLOJECT SPRAY SET	9914	Cancelled · Class 2	Aug 1999
TRANSFER SET	7697	Discontinued at renewal · Class 2	Jul 1999
IV BLOOD ADMINISTRATION SET	4569	Cancelled · Class 2	Jun 1999
BURETROL FILTER	4409	Discontinued at renewal · Class 2	Jun 1999
SECONDARY MEDICATION SET (SMS)	4416	Discontinued at renewal · Class 2	Jun 1999
STERILE ARTERIO-VENOUS BLOODLINE (DUAL PUMP)	2543	Cancelled · Class 2	Apr 1999
STERILE ARTERIO-VENOUS BLOODLINE (SINGLE PUMP)	2545	Cancelled · Class 2	Apr 1999

Notices of Compliance

Newest first.

CAELYXMay 8, 2026 · NOC 37505 · Supplement to a New Drug Submission (SNDS)
CEFAZOLIN IN DEXTROSE INJECTION, USPApril 23, 2026 · NOC 37388 · Supplement to an Abbreviated New Drug Submission (SANDS)
UROMITEXANMarch 16, 2026 · NOC 37115 · Supplement to a New Drug Submission (SNDS)
CAELYXFebruary 12, 2026 · NOC 36896 · Supplement to a New Drug Submission (SNDS)
PROPOFOL INJECTIONDecember 12, 2025 · NOC 36565 · Supplement to an Abbreviated New Drug Submission (SANDS)
ERIBULIN MESYLATE INJECTIONOctober 10, 2025 · NOC 36152 · Abbreviated New Drug Submission (ANDS)
TISSEELOctober 9, 2025 · NOC 36203 · Supplement to a New Drug Submission (SNDS)
MICAFUNGIN IN 0.9% SODIUM CHLORIDE INJECTIONSeptember 17, 2025 · NOC 36020 · Abbreviated New Drug Submission (ANDS)
ARTISSSeptember 3, 2025 · NOC 36109 · Supplement to a New Drug Submission (SNDS)
0.4% LIDOCAINE HYDROCHLORIDE AND 5% DEXTROSE INJECTIONJuly 21, 2025 · NOC 35700 · Supplement to a New Drug Submission (SNDS)
DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION, USPApril 14, 2025 · NOC 35195 · Supplement to an Abbreviated New Drug Submission (SANDS)
CEFAZOLIN IN DEXTROSE INJECTION, USPMarch 6, 2025 · NOC 34962 · Supplement to an Abbreviated New Drug Submission (SANDS)
OLIMEL 3.3% E; OLIMEL 4.4% E; OLIMEL 5.7% E; OLIMEL 7.6% E; PERIOLIMEL 2.5% EMarch 4, 2025 · NOC 34938 · Supplement to a New Drug Submission (SNDS)
OLIMEL 4.4%; OLIMEL 5.7%; OLIMEL 7.6%March 4, 2025 · NOC 34941 · Supplement to a New Drug Submission (SNDS)
RECOTHROMFebruary 17, 2025 · NOC 34863 · Supplement to a New Drug Submission (SNDS)
CAELYXFebruary 10, 2025 · NOC 34814 · Supplement to a New Drug Submission (SNDS)
CEFTRIAXONE INJECTION, USPJanuary 16, 2025 · NOC 34708 · Supplement to an Abbreviated New Drug Submission (SANDS)
IFEXNovember 12, 2024 · NOC 34362 · Supplement to a New Drug Submission (SNDS)
METRONIDAZOLE INJECTION, USPOctober 8, 2024 · NOC 34159 · Supplement to a New Drug Submission (SNDS)
CLINIMIX EJuly 19, 2024 · NOC 33675 · Supplement to a New Drug Submission (SNDS)
CLINIMIX EJuly 19, 2024 · NOC 33676 · Supplement to a New Drug Submission (SNDS)
CLINIMIXJuly 19, 2024 · NOC 33688 · Supplement to a New Drug Submission (SNDS)
CLINDAMYCIN INJECTION IN 5% DEXTROSEMay 16, 2024 · NOC 33246 · Supplement to an Abbreviated New Drug Submission (SANDS)
CAELYXApril 2, 2024 · NOC 32975 · Supplement to a New Drug Submission (SNDS)
BUPIVACAINE HYDROCHLORIDE INJECTION, USPJanuary 9, 2024 · NOC 32494 · Supplement to an Abbreviated New Drug Submission (SANDS)
MIDAZOLAM INJECTION, USPNovember 28, 2023 · NOC 32255 · Supplement to an Abbreviated New Drug Submission (SANDS)
METOCLOPRAMIDE HYDROCHLORIDE INJECTIONNovember 14, 2023 · NOC 32091 · Supplement to an Abbreviated New Drug Submission (SANDS)
DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION, USPNovember 10, 2023 · NOC 32104 · Supplement to an Abbreviated New Drug Submission (SANDS)
REGIOCITNovember 3, 2023 · NOC 32021 · Supplement to a New Drug Submission (SNDS)
KETAMINE INJECTION, BPOctober 10, 2023 · NOC 31849 · Supplement to an Abbreviated New Drug Submission (SANDS)
FLUCONAZOLE IN SODIUM CHLORIDE INJECTION USPSeptember 21, 2023 · NOC 31694 · Supplement to an Abbreviated New Drug Submission (SANDS)
ONDANSETRON INJECTION, USPSeptember 6, 2023 · NOC 31562 · Supplement to an Abbreviated New Drug Submission (SANDS)
ONDANSETRON INJECTION, USPAugust 11, 2023 · NOC 31403 · Supplement to an Abbreviated New Drug Submission (SANDS)
CLINOLEIC 20%August 3, 2023 · NOC 31367 · Supplement to a New Drug Submission (SNDS)
AXBERI; AXBERI HPJuly 27, 2023 · NOC 31320 · New Drug Submission (NDS)
OLIMEL 4.4%; OLIMEL 5.7%; OLIMEL 7.6%July 19, 2023 · NOC 31273 · Supplement to a New Drug Submission (SNDS)
OLIMEL 3.3% E; OLIMEL 4.4% E; OLIMEL 5.7% E; OLIMEL 7.6% E; PERIOLIMEL 2.5% EJuly 19, 2023 · NOC 31274 · Supplement to a New Drug Submission (SNDS)
SUPRANEJuly 5, 2023 · NOC 31128 · Supplement to a New Drug Submission (SNDS)
SEVOFLURANEMarch 9, 2023 · NOC 30282 · Supplement to an Abbreviated New Drug Submission (SANDS)
DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION, USPJanuary 4, 2023 · NOC 29844 · Supplement to an Abbreviated New Drug Submission (SANDS)
CEFAZOLIN INJECTION, USPNovember 10, 2022 · NOC 29429 · Supplement to an Abbreviated New Drug Submission (SANDS)
FLUCONAZOLE IN SODIUM CHLORIDE INJECTION USPOctober 19, 2022 · NOC 29239 · Supplement to an Abbreviated New Drug Submission (SANDS)
HEPARIN SODIUM IN 0.9% SODIUM CHLORIDE INJECTIONOctober 18, 2022 · NOC 29222 · Supplement to a New Drug Submission (SNDS)
METOCLOPRAMIDE HYDROCHLORIDE INJECTIONOctober 7, 2022 · NOC 29163 · Abbreviated New Drug Submission (ANDS)
METRONIDAZOLE INJECTION, USPSeptember 21, 2022 · NOC 29032 · Supplement to a New Drug Submission (SNDS)
PROPOFOL INJECTIONAugust 16, 2022 · NOC 28765 · Supplement to an Abbreviated New Drug Submission (SANDS)
MYXREDLINAugust 3, 2022 · NOC 28702 · New Drug Submission (NDS)
ONDANSETRON INJECTION, USPJuly 26, 2022 · NOC 28651 · Supplement to an Abbreviated New Drug Submission (SANDS)
TRANEXAMIC ACID INJECTION, USPJuly 21, 2022 · NOC 28624 · Supplement to an Abbreviated New Drug Submission (SANDS)
MIDAZOLAM INJECTION, USPJuly 19, 2022 · NOC 28617 · Abbreviated New Drug Submission (ANDS)
TISSEELJuly 7, 2022 · NOC 28561 · Supplement to a New Drug Submission (SNDS)
ONDANSETRON INJECTION, USPMay 17, 2022 · NOC 28196 · Abbreviated New Drug Submission (ANDS)
CLINIMIX EApril 1, 2022 · NOC 27894 · Supplement to a New Drug Submission (SNDS)
CLINIMIXApril 1, 2022 · NOC 27895 · Supplement to a New Drug Submission (SNDS)
CLINIMIX EApril 1, 2022 · NOC 27896 · Supplement to a New Drug Submission (SNDS)
CLINIMIXApril 1, 2022 · NOC 27900 · Supplement to a New Drug Submission (SNDS)
CLINIMIX EApril 1, 2022 · NOC 27901 · Supplement to a New Drug Submission (SNDS)
ACETAMINOPHEN INJECTIONMarch 28, 2022 · NOC 27842 · Supplement to an Abbreviated New Drug Submission (SANDS)
HEPARIN SODIUM IN 0.9% SODIUM CHLORIDE INJECTIONMarch 22, 2022 · NOC 27802 · Supplement to a New Drug Submission (SNDS)
KETAMINE INJECTION, BPMarch 8, 2022 · NOC 27728 · Abbreviated New Drug Submission (ANDS)
CAELYXMarch 4, 2022 · NOC 27717 · New Drug Submission (NDS)
ARTISSJanuary 28, 2022 · NOC 27500 · Supplement to a New Drug Submission (SNDS)
POTASSIUM CHLORIDE INJECTIONJanuary 13, 2022 · NOC 27379 · Supplement to a New Drug Submission (SNDS)
ACETAMINOPHEN INJECTIONAugust 26, 2021 · NOC 26504 · Abbreviated New Drug Submission (ANDS)
DAPTOMYCIN FOR INJECTION RFAugust 5, 2021 · NOC 26376 · Abbreviated New Drug Submission (ANDS)
NALOXONE HYDROCHLORIDE INJECTION, USPJuly 15, 2021 · NOC 26269 · Abbreviated New Drug Submission (ANDS)
PROPOFOL INJECTIONJune 7, 2021 · NOC 26010 · Supplement to an Abbreviated New Drug Submission (SANDS)
TISSEELMay 17, 2021 · NOC 25892 · Supplement to a New Drug Submission (SNDS)
OLIMEL 4.4%; OLIMEL 5.7%; OLIMEL 7.6%April 19, 2021 · NOC 26041 · Supplement to a New Drug Submission (SNDS)
OLIMEL 3.3% E; OLIMEL 4.4% E; OLIMEL 5.7% E; OLIMEL 7.6% E; PERIOLIMEL 2.5% EApril 19, 2021 · NOC 26092 · Supplement to a New Drug Submission (SNDS)
20% PROSOLApril 13, 2021 · NOC 25647 · Supplement to a New Drug Submission (SNDS)
DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION, USPMarch 19, 2021 · NOC 25467 · Abbreviated New Drug Submission (ANDS)
ONDANSETRON INJECTION, USPJanuary 6, 2021 · NOC 24956 · Supplement to an Abbreviated New Drug Submission (SANDS)
FLUCONAZOLE IN SODIUM CHLORIDE INJECTION USPNovember 6, 2020 · NOC 24580 · Supplement to an Abbreviated New Drug Submission (SANDS)
TISSEELOctober 27, 2020 · NOC 24509 · Supplement to a New Drug Submission (SNDS)
CEFAZOLIN INJECTION, USPSeptember 18, 2020 · NOC 24258 · Supplement to an Abbreviated New Drug Submission (SANDS)
TRANEXAMIC ACID INJECTION, USPSeptember 18, 2020 · NOC 24260 · Abbreviated New Drug Submission (ANDS)
CLINIMIX; CLINIMIX EAugust 25, 2020 · NOC 24209 · Supplement to a New Drug Submission (SNDS)
CEFTRIAXONE INJECTION, USPJune 2, 2020 · NOC 23697 · Abbreviated New Drug Submission (ANDS)
ONDANSETRON INJECTION, USPMay 19, 2020 · NOC 23620 · Abbreviated New Drug Submission (ANDS)
IFEXMay 6, 2020 · NOC 23565 · Supplement to a New Drug Submission (SNDS)
CLINIMIX 6% AMINO ACIDS (BLEND D) WITHOUT ELECTROLYTES IN 5% DEXTROSE INJECTION; CLINIMIX 8% AMINO ACIDS (BLEND D) WITHOUT ELECTROLYTES IN 10% DEXTROSE INJECTION; CLINIMIX 8% AMINO ACIDS (BLEND D) WITHOUT ELECTROLYTES IN 14% DEXTROSE INJECTION; CLINIMIX E 8% AMINO ACIDS (BLEND D) WITH ELECTROLYTES IN 10% DEXTROSE WIITH CALCIUM INJECTION; CLINIMIX E 8% AMINO ACIDS (BLEND D) WITH ELECTROLYTES IN 14% DEXTROSE WIITH CALCIUM INJECTIONApril 29, 2020 · NOC 23678 · Supplement to a New Drug Submission (SNDS)
PROPOFOL INJECTIONApril 20, 2020 · NOC 23482 · Abbreviated New Drug Submission (ANDS)
REGIOCITMarch 3, 2020 · NOC 23292 · New Drug Submission (NDS)
CEFAZOLIN INJECTION, USPFebruary 18, 2020 · NOC 23220 · Abbreviated New Drug Submission (ANDS)
UROMITEXANJanuary 7, 2020 · NOC 23081 · Supplement to a New Drug Submission (SNDS)
0.4% LIDOCAINE HYDROCHLORIDE AND 5% DEXTROSE INJECTIONDecember 20, 2019 · NOC 23042 · Supplement to an Abbreviated New Drug Submission (SANDS)
OLIMEL 3.3% E; OLIMEL 4.4%; OLIMEL 4.4% E; OLIMEL 5.7%; OLIMEL 5.7% E; OLIMEL 7.6%; OLIMEL 7.6% E; PERIOLIMEL 2.5% EDecember 20, 2019 · NOC 23045 · Supplement to a New Drug Submission (SNDS)
PROCYTOXNovember 22, 2019 · NOC 22923 · Supplement to a New Drug Submission (SNDS)
OLIMEL 7.6%; OLIMEL 7.6% EOctober 9, 2019 · NOC 22764 · Supplement to a New Drug Submission (SNDS)
POTASSIUM CHLORIDE INJECTIONOctober 8, 2019 · NOC 22765 · Supplement to a New Drug Submission (SNDS)
GENTAMICIN(E)September 13, 2019 · NOC 22653 · Supplement to a New Drug Submission (SNDS)
METRONIDAZOLE INJECTION, USPSeptember 3, 2019 · NOC 22595 · Supplement to a New Drug Submission (SNDS)
BUPIVACAINE HYDROCHLORIDE INJECTION, USPMay 23, 2019 · NOC 22184 · Abbreviated New Drug Submission (ANDS)
FUROSEMIDE INJECTION, USPMay 21, 2019 · NOC 22171 · Abbreviated New Drug Submission (ANDS)
VANCOMYCIN INJECTION USP IN 0.9% SODIUM CHLORIDE; VANCOMYCIN INJECTION USP IN 5% DEXTROSEApril 5, 2019 · NOC 22039 · Abbreviated New Drug Submission (ANDS)
CLINDAMYCIN INJECTION IN 5% DEXTROSEFebruary 4, 2019 · NOC 21825 · Abbreviated New Drug Submission (ANDS)
RECOTHROMJanuary 4, 2019 · NOC 21691 · New Drug Submission (NDS)
CIPROFLOXACIN INJECTIONOctober 19, 2018 · NOC 21447 · Supplement to an Abbreviated New Drug Submission (SANDS)
CIPROFLOXACIN INJECTIONJuly 5, 2018 · NOC 21056 · Abbreviated New Drug Submission (ANDS)

The latest 100 of 198.

Recalls and safety alerts that mention its products

Health Canada’s recall notices do not carry licence numbers, so these are matched by name. A notice may cover another product or only some lots: read it to see what it covers.

Dianeal PD4 2.5% Dextrose and Physioneal 40 2.27% Glucose peritoneal dialysis solutions recalled due to risk of leakage at connection siteJune 15, 2024 · Drugs · Product safety
Dianeal PD4 2.5% Dextrose and Physioneal 40 2.27% Glucose peritoneal dialysis solutions recalled due to risk of leakage at connection siteJune 14, 2024 · Drugs · Product quality · Type I
Tisseel Kit; Out-of-specification (Dissolution)May 23, 2024 · Biologic or vaccine · Product quality · Type II
Dianeal PD4 CAPD (2019-11-13)November 13, 2019 · Drugs · Product safety · Type III
DIANEAL PD4 CAPD SOLUTION WITH 1.5% DEXTROSE AND 2.5MEQ/L CALCIUM (2018-01-17)January 17, 2018 · Drugs · Product safety · Type I
DIANEAL PD4 CAPD SOLUTION WITH 1.5% DEXTROSE AND 2.5MEQ/L CALCIUM (2017-11-03)November 16, 2017 · Drugs · Product safety · Type III
Primene 10% Amino Acid Solution, 250 mL - Compatibility Issue with Trace Elements - UpdateNovember 23, 2015 · Drugs · Product safety
PRIMING/RECIRCULATION BAG, 2L (2015-10-14)October 14, 2015 · Medical devices · Health products · Type III
Primene 10% Amino Acid Injection, 250 mL, Pharmacy Bulk Pack - Compatibility Issue with Trace Elements - Important Information Updates on All LotsApril 21, 2015 · Drugs · Product safety
Primene 10% Amino Acid Injection, 250 mL, Pharmacy Bulk Pack - Compatibility Issue with Trace ElementsApril 10, 2015 · Drugs · Product safety
Buretrol Solution Set with Clearlink and Interlink (2014-07-04)August 8, 2014 · Medical devices · Medical devices · Type I
Viaflex container with connector (2013-11-26)March 20, 2014 · Medical devices · Medical devices · Type III
CLINOLEIC 20% - Potential for the Presence of Particles from the Administration Port Material - For Health ProfessionalsJuly 16, 2013 · Drugs · Product safety
CLINOLEIC 20% - Potential for the Presence of Particles from the Administration Port Material - For the PublicJuly 16, 2013 · Drugs · Product safety
Mesna (Uromitexan), Multi-Dose Vials - Association with Fatal Gasping Syndrome in Neonates and Infants - For the PublicSeptember 6, 2011 · Drugs
Mesna (Uromitexan), Multi-Dose Vials - Association with Fatal Gasping Syndrome in Neonates and Infants - For Health ProfessionalsSeptember 6, 2011 · Drugs